Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590)

Aarti K. Bhatia, Ju Whei Lee, Harlan A. Pinto, Charlotte D. Jacobs, Paul J. Limburg, Philip Rubin, Robert M. Arusell, Eamonn P. Dunphy, Janardan D. Khandekar, Seth A. Reiner, Luis Baez-Diaz, Paul Celano, Shuli Li, Yi Li, Barbara A. Burtness, George L. Adams, Kishan J. Pandya

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590)'. Together they form a unique fingerprint.

Medicine & Life Sciences